Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / The Schall Law Firm

United States — Food and Drug Administration & The Schall Law Firm

2 shared events · Importance 3 · Last updated May 14, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (2)
49
Regulatory
Atara Biotherapeutics Faces Securities Lawsuit
United States — Food and Drug Administration: The United States — Food and Drug Administration's potential non-approval of Atara Biotherapeutics' BLA for tabelecleucel due to manufacturing problems and study deficiencies is a key point in the lawsuit.
The Schall Law Firm: The The Schall Law Firm is representing investors in a class action lawsuit against Atara Biotherapeutics, alleging securities fraud.
May 01, 2026 · 6 articles
0
Business
UniQure Securities Fraud Class Action
Apr 02, 2026 · 20 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and The Schall Law Firm interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.